BiotechTube
Discover
News
Company
Sign in
BiotechTube
Home
/
Nacuity Pharmaceuticals
/
Jami R. Kern, MBA, PhD
JR
Jami R. Kern, MBA, PhD
SVP, Chief Clinical Officer
Nacuity Pharmaceuticals
Therapeutic Areas
Ophthalmology
Rare Diseases
Nacuity Pharmaceuticals Pipeline
Drug
Indication
Phase
NPI-001
Retinitis Pigmentosa
Phase 2/3
Leadership Team at Nacuity Pharmaceuticals
HC
Halden Conner
Chairman, CEO, Co-Founder
GM
G. Michael Wall, PhD
SVP, Chief Scientific Officer
LA
Lee Anderson, MD
Ophthalmologist in Residence
CL
Charles Lieser, JD, CPA
CFO
View full Nacuity Pharmaceuticals profile